Applied Proteomics and Interactomics external website

Bioinformatics & Structural Biochemistry Department

Applied Proteomics and Interactomics

The Applied Proteomics and Interactomics group focus on developing mass spectrometry-based omics technologies for biomolecular research under the IBAR service facility for chromatography and mass spectrometry analysis (Protein Chemistry Facility - PCF) performing protein, peptide, proteome and subproteome analysis. The facility was established in 2012 by a EU funded grant PROCERA (POSCCE-A2-O2.2.1-2009-4) in the Department of Bioinformatics and Structural Biochemistry (IBAR-DBSB).

Its main research topics are closely related with the focus-area of other groups and departments of IBAR: proteome and subproteome characterization in melanoma, protein-protein interactions in biological systems, co- and post-translational modification analysis with a special focus on glycosylation, imunopeptidome investigation, identification of specific protein interactors. Another priority is the study of protein phosphorylation, a dynamic process that implies the complementary activities of protein kinases and protein phosphatases. Mass spectrometric analysis of the samples implies the use of CID, HCD and ETD fragmentation methods. Data analysis and interpretation of results is made using Thermo Scientific™ Proteome Discoverer™ software. For phosphosite localization, besides the automated analysis (PhosphoRS Node in Proteome Discoverer) a manual inspection of the raw tandem mass spectra of the peptide is often made.

As a service unit the facility can provide the following methods of analysis:

  • analytical and preparative HPLC of small molecules and biomolecules
  • nanoHPLC separation of peptides
  • low-/high-resolution mass spectrometry (MS) and tandem MS
  • sample preparation of proteins and peptides for LC/MS analysis (spectrophotometric -UV-VIS, fluorimetric and electrophoretic methods -SDS-PAGE)
  • bioinformatic MS data analysis
  • batch or column fast protein chromatography
Cristian Munteanu, Dr.
Cristian Munteanu, Dr.

Research Scientist

ACADEMIC CAREER 2019: Research Scientist (CS) III at the Institute of Biochemistry of the Romanian Academy (IBRA) 2016 – 2019: Research Scientist (CS) at the Institute of Biochemistry of the Romanian Academy (IBRA) 2014 – 2016: Research Assistant at IBRA EDUCATION AND TRAINING 2012 – 2017: Ph.D. in Biology at Institute of Biochemistry of the Romanian Academy (IBRA) with the thesis title: “Insights into functional interaction proteomics of endoplasmic reticulum associated degradation (ERAD) and antigen presentation in melanoma using mass spectrometry”, Coordinators: Dr. Andrei Jose Petrescu/Dr. Niculina Mitrea (University of Medi More...

Aura-Elena Ionescu, PhD
Aura-Elena Ionescu, PhD

Scientific Researcher

Born: 19th of November 1988, Ploiesti, Romania 2003 - 2007: „Ion Luca Caragiale” National College, Ploieşti, Romania 2007- 2012: Faculty of Pharmacy at University of Medicine and Pharmacy "Carol Davila" Buchare More...

Gabriela Chiritoiu, PhD
Gabriela Chiritoiu, PhD

Scientific Researcher III

Gabriela Chiritoiu graduated from Faculty of Chemistry, University of Bucharest (2004-2008). She received her Ph.D. in Biology from the Institute of Biochemistry of the Romanian Academy in 2016, under the supervision of dr More...

Ioana Militaru, PhD
Ioana Militaru, PhD

Ioana Militaru is a researcher in the Institute of Biochemistry of the Romanian Academy. Ioana is currently working in Molecular Cell Biology in the Molecular Cell Biology.

Microfluidic assay of FGF2 therapeutic administration for bone regeneration 2017-2019
Acronym: μFGF2bone
Project director: Gabriela Chiritoiu

Musculoskeletal disorders affect 1 in 7 people and fractures alone affect 1 in 50 people annually while 10% of bone injuries fail to heal. Our present proposal aims to test for the first time the potential of fibroblast growth factor-2 (FGF2), to be administered as a stimulatory drug to enhance bone regeneration.

Mass spectrometry based investigation of the oxidative stress as a potential key-player in the immunobiology of melanoma 02/05/2018 - 31/08/2020
Acronym: IMUNOPEP
Budget: 250 000 RON
Project director: Cristian Munteanu

Identification of new molecules involved in melanoma associated antigens production 2020-2022
Acronym: ImmunoMOD
Budget: 246,950 RON
Project director: Gabriela Chiritoiu

This project aims to develop new strategies to improve the capacity of antigen presenting tumor cells to activate cytotoxic T cells and hamper immune escape mechanisms in cancer.

Dental plaque multi-omics dissection for the exploration of novel targets in translational biology 2024-2026
Acronym: DENTALPLAQUEOMICS
Budget: 477500
Project director: Cristian Munteanu